Basic Information
ID: ALA5261633
Type: Binding
Description: Inhibition of BRD9 in human PC-9 cells assessed as reduction in ALDH1A1 gene expression at 0.8 uM preincubated with erlotinib for 8 days followed by compound addition and measured after 24 hrs by RNA sequencing analysis
Organism: Homo sapiens
Cell type: PC-9
Activity Charts
Bioactivity
Activity Types for Assay ALA5261633
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 396.49 | 4.13 | 4.13 |